Thomas Jandl

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Safety and efficacy of zandelisib plus zanubrutinib in previously treated follicular and mantle cell lymphomas”.

Safety and efficacy of zandelisib plus zanubrutinib in previously treated follicular and mantle cell lymphomas

British Journal of Haematology(2024)10.1111/bjh.19419

N/A

0DataRank · unranked

5 citations

Catherine Diefenbach, Deepa Jagadeesh, Adam Asch, Abhijeet Kumar, Michaela L. Tsai +11 more

Randomized, multi-center study of carfilzomib, lenalidomide, and dexamethasone (KRd) with or without daratumumab (D) in patients with newly diagnosed multiple myeloma (NDMM): The ADVANCE clinical trial.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.7503

N/A

0DataRank · unranked

10 citations

Jing Christine Ye, Jens Hillengaß, Douglas W. Sborov, James E. Hoffman, Benjamin Diamond +15 more